Log in

Relevant bibliographies by topics / Multiple Sclerosis Impact Scale / Journal articles

To see the other types of publications on this topic, follow the link: Multiple Sclerosis Impact Scale.

Journal articles on the topic 'Multiple Sclerosis Impact Scale'

Author: Grafiati

Published: 3 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Multiple Sclerosis Impact Scale.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Parkerson, Holly A., Melissa D. Kehler, Donald Sharpe, and Heather D. Hadjistavropoulos. "Coping with Multiple Sclerosis Scale." International Journal of MS Care 18, no. 4 (2016): 192–200. http://dx.doi.org/10.7224/1537-2073.2015-031.

Full text

Abstract:

Background: The Coping with Multiple Sclerosis Scale (CMSS) was developed to assess coping strategies specific to multiple sclerosis (MS). Despite its wide application in MS research, psychometric support for the CMSS remains limited to the initial factor analytic investigation by Pakenham in 2001. Methods: The current investigation assessed the factor structure and construct validity of the CMSS. Participants with MS (N = 453) completed the CMSS, as well as measures of disability related to MS (Multiple Sclerosis Impact Scale), quality of life (World Health Organization Quality of Life Brief

APA, Harvard, Vancouver, ISO, and other styles

2

Dr., S. S. Subramanian*. "TEN YEARS FOLLOW UP OF MULTIPLE SCLEROSIS WITH PHYSIOTHERAPY – EVIDENCE BASED STUDY." Indian Journal of Medical Research and Pharmaceutical Sciences 4, no. 6 (2017): 72–77. https://doi.org/10.5281/zenodo.815712.

Full text

Abstract:

Multiple sclerosis, a progressive neurological degenerative disease, where physical, psychological and social aspects of rehabilitation is required on long term, with periodical evaluation and physiotherapy. This original study with 10 years follow up on a subject with multiple sclerosis highlights the clinical course and high lighten the impact of physiotherapy with evidence. Though the results of this study was negative with multiple sclerosis impact scale 29 increasing, along with expanded disability status doubling, physiotherapy has its domain in preventing, maintaining and provide better

APA, Harvard, Vancouver, ISO, and other styles

3

McMillan, Lindsay, and Kathleen A. Moore. "The Development and Validation of the Impact of Multiple Sclerosis Scale and the Symptoms of Multiple Sclerosis Scale." Archives of Physical Medicine and Rehabilitation 87, no. 6 (2006): 832–41. http://dx.doi.org/10.1016/j.apmr.2006.01.024.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Hayton, T., J. Furby, K. J. Smith, et al. "Clinical and imaging correlates of the multiple sclerosis impact scale in secondary progressive multiple sclerosis." Journal of Neurology 259, no. 2 (2011): 237–45. http://dx.doi.org/10.1007/s00415-011-6151-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Gulick, Elsie E., Marie Namey, and June Halper. "Monitoring My Multiple Sclerosis." International Journal of MS Care 13, no. 3 (2011): 137–45. http://dx.doi.org/10.7224/1537-2073-13.3.137.

Full text

Abstract:

Optimal health of people with multiple sclerosis (MS) can be promoted by patients' sharing of health information gained through periodic self-monitoring with their health-care providers. The purpose of this study was to develop a valid and reliable self-administered scale to obtain information about MS patients' health status and the impact of the disease on their daily lives. We named this scale “Monitoring My Multiple Sclerosis” (MMMS). A cross-sectional survey was conducted of 171 MS patients who completed the MMMS and Patient-Determined Disease Steps (PDDS) scales and provided information

APA, Harvard, Vancouver, ISO, and other styles

6

Bosma, LVAE, JM Sonder, JJ Kragt, CH Polman, and BMJ Uitdehaag. "Detecting clinically-relevant changes in progressive multiple sclerosis." Multiple Sclerosis Journal 21, no. 2 (2014): 171–79. http://dx.doi.org/10.1177/1352458514540969.

Full text

Abstract:

Objective: To investigate which changes in different clinical outcome measures contribute most to increased disease impact, as reported by the patient, in progressive multiple sclerosis (MS). Methods: From a cohort of prospectively-followed MS patients, we selected progressive patients with two visits, 4–6 years apart. We assessed long-term changes on the Expanded Disability Status Scale (EDSS), Timed 25-Foot Walk (T25FW), 9-Hole Peg Test (9HPT) and Guy’s Neurological Disability Scale (GNDS). We defined the presence or absence of clinically meaningful change by using the Multiple Sclerosis Imp

APA, Harvard, Vancouver, ISO, and other styles

7

Ghahari, Setareh, Lana S. Khoshbin, and Susan J. Forwell. "The Multiple Sclerosis Self-Management Scale." International Journal of MS Care 16, no. 2 (2014): 61–67. http://dx.doi.org/10.7224/1537-2073.2013-019.

Full text

Abstract:

Background: The Multiple Sclerosis Self-Management Scale (MSSM) is currently the only measure that was developed specifically to address self-management among individuals with multiple sclerosis (MS). While good internal consistency (α = 0.85) and construct validity have been demonstrated, other psychometric properties have not been established. This study was undertaken to evaluate the criterion validity, test-retest reliability, and face validity of the MSSM. Methods: Thirty-one individuals with MS who met the inclusion criteria were recruited to complete a series of questionnaires at two ti

APA, Harvard, Vancouver, ISO, and other styles

8

Pérez-Miralles, Francisco, Daniel Prefasi, Antonio García-Merino, et al. "Perception of stigma in patients with primary progressive multiple sclerosis." Multiple Sclerosis Journal - Experimental, Translational and Clinical 5, no. 2 (2019): 205521731985271. http://dx.doi.org/10.1177/2055217319852717.

Full text

Abstract:

Stigma associated with neurological disorders may contribute to a poor health-related quality of life. However, limited information is available in primary progressive multiple sclerosis. We investigated the presence and impact of stigma in patients with primary progressive multiple sclerosis. A non-interventional, cross-sectional study was conducted. A total of 55 primary progressive multiple sclerosis patients were studied (mean age 55.8±9.5 years, 56.4% male). The median Expanded Disability Status Scale score was 5.5 (4.0–6.5). Stigma prevalence was 78.2% ( n=43). Twenty-four patients (43.6

APA, Harvard, Vancouver, ISO, and other styles

9

Rosenberg, Jay H. "Pharmacologic Therapy for Multiple Sclerosis–Related Fatigue." International Journal of MS Care 7, no. 1 (2005): 22–27. http://dx.doi.org/10.7224/1537-2073-7.1.22.

Full text

Abstract:

Fatigue is the most common symptom of multiple sclerosis and is perhaps the symptom with the most devastating impact on patient well-being. It is reported by 75% to 95% of individuals, and more than half describe it as the worst symptom of the disease. The mechanisms underlying the development of fatigue remain unclear; although fatigue is believed to be a primary symptom of MS (ie, related to the demyelinating processes of the disease), fatigue may also occur secondarily to factors such as sleep disturbances, depression, or the effects of medications. The highly variable presentation of MS an

APA, Harvard, Vancouver, ISO, and other styles

10

Benito-León, J., P. Martínez-Martín, B. Frades, et al. "Impact of fatigue in multiple sclerosis: the Fatigue Impact Scale for Daily Use (D-FIS)." Multiple Sclerosis Journal 13, no. 5 (2007): 645–51. http://dx.doi.org/10.1177/1352458506073528.

Full text

Abstract:

Objective The Fatigue Impact Scale for Daily Use (D-FIS) is an eight-item instrument designed to measure subjective daily experience of fatigue. This study sought to determine the metric properties of the D-FIS in multiple sclerosis (MS) patients. Methods Sixty-eight patients with operationally-defined MS and fatigue (54.8% of the sample) underwent the D-FIS. Usual clinical measures for MS, the Montgomery-Asberg Depression Rating Scale (MADRS) and the Functional Assessment of Multiple Sclerosis (FAMS) were also applied. In addition, patients with fatigue completed the Fatigue Descriptive Scale

APA, Harvard, Vancouver, ISO, and other styles

11

Thompson, A. J. "Measuring handicap in multiple sclerosis." Multiple Sclerosis Journal 5, no. 4 (1999): 260–62. http://dx.doi.org/10.1177/135245859900500411.

Full text

Abstract:

Handicap, shortly to be renamed participation, is a well defined though somewhat neglected entity which addresses an important aspect of the impact disease has on the individual. It is particularly relevant in Multiple Sclerosis (MS) which has such a major impact on issues such as employment, relationships, transport and social integration. Few validated measuring tools exist, and the generic London Handicap Scale is probably the best currently available but is only appropriate for group comparison. Handicap should be monitored in MS and is particularly appropriate in the evaluation of rehabil

APA, Harvard, Vancouver, ISO, and other styles

12

Sonder, JM, LVAE Bosma, FAH van der Linden, DL Knol, CH Polman, and BMJ Uitdehaag. "Proxy measurements in multiple sclerosis: agreement on different patient-reported outcome scales." Multiple Sclerosis Journal 18, no. 2 (2011): 196–201. http://dx.doi.org/10.1177/1352458511417827.

Full text

Abstract:

Background: Patient-reported outcome (PRO) scales are often used in multiple sclerosis (MS) research. Full understanding of items can be influenced by disease worsening, mood disturbances and cognitive problems of the MS patient. Earlier research with the Multiple Sclerosis Impact Scale (MSIS-29) showed that proxy respondents (i.e. partners of patients) can provide useful information. Objective: To determine agreement between patients and proxy respondents on different MS PRO scales. Methods: 139 Patients and partners completed the MSIS-29 (Physical and Psychological scale), Multiple Sclerosis

APA, Harvard, Vancouver, ISO, and other styles

13

Fitzgerald, Shawn M., Jian Li, Phillip D. Rumrill, William Merchant, and Malachy Bishop. "Examining the factor structure of the Multiple Sclerosis Impact Scale." Work 49, no. 3 (2014): 523–38. http://dx.doi.org/10.3233/wor-131669.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Fisk, John D., Amanda Pontefract, Paul G. Ritvo, Catherine J. Archibald, and T. J. Murray. "The Impact of Fatigue on Patients with Multiple Sclerosis." Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 21, no. 1 (1994): 9–14. http://dx.doi.org/10.1017/s0317167100048691.

Full text

Abstract:

ABSTRACT:Although fatigue is recognized as a symptom of MS, there have been insufficient methods for evaluating this symptom. We administered the Fatigue Impact Scale to 85 MS patients and 20 hypertensive patients. Neurologic impairment, mental health, and general health status were also assessed. MS patients reported significantly higher fatigue impact than hypertensive patients. Most MS patients reported fatigue as either their worst (14%), or one of their worst (55%) symptoms. Disease classification and neurologic impairment had little bearing on Fatigue Impact Scale scores in the MS sample

APA, Harvard, Vancouver, ISO, and other styles

15

Sretenović, Ivana, Srećko Potić, Goran Nedović, Gordana Odović, and Ljiljana Šimpraga. "Functional Mobility Assessment in People with Multiple Sclerosis." Neurology International 17, no. 5 (2025): 63. https://doi.org/10.3390/neurolint17050063.

Full text

Abstract:

Background/Objectives: Functional mobility includes gait and balance. People with multiple sclerosis often experience gait impairment and difficulties with walking, as well as an increased risk of falling. The aim of the research was to assess functional mobility and to examine the relationship between gait and balance in people with multiple sclerosis, as well as the impact of falls on these two variables. Methods: The study sample consisted of 92 people with multiple sclerosis, with an average age of 45.10 (SD = 9.57) years, and both sexes (82.6% were female). The Activities-specific Balance

APA, Harvard, Vancouver, ISO, and other styles

16

Calabrese, Massimiliano, Francesca Rinaldi, Paola Grossi, et al. "Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing—remitting multiple sclerosis." Multiple Sclerosis Journal 16, no. 10 (2010): 1220–28. http://dx.doi.org/10.1177/1352458510376405.

Full text

Abstract:

Background: Fatigue is one of the most frequent symptoms suffered by patients affected by multiple sclerosis. The patho-physiological basis of multiple sclerosis-related fatigue remains to be elucidated. Objective: Our aim was to investigate whether a particular pattern of deep and/or cortical grey matter atrophy is associated with fatigue in patients with multiple sclerosis. Methods: A total of 152 patients with relapsing—remitting multiple sclerosis were evaluated with the Expanded Disability Status Scale, the Fatigue Severity Status Scale (FSS), the Modified Fatigue Impact Scale and the Bec

APA, Harvard, Vancouver, ISO, and other styles

17

Odzimek, Martyna, Hubert Lipiński, Małgorzata Błaszczyk, et al. "Cervical Spine Pain and the Impact on the Quality of Life of Patients with Multiple Sclerosis." Medicina 60, no. 12 (2024): 1923. http://dx.doi.org/10.3390/medicina60121923.

Full text

Abstract:

Background and Objectives: The main aim of this study was to evaluate the impact of cervical pain on the quality of life of patients with multiple sclerosis in comparison with a group of healthy people (without diseases of the Central Nervous System). Materials and Methods: Data were collected at the Specialist Hospital St. Łukasz in Końskie (Poland) in the period from November 2023 to August 2024. The inclusion criteria for this study were as follows: age (20–50 years), women and men, healthy people (without diseases of the Central Nervous System) and people suffering from multiple sclerosis.

APA, Harvard, Vancouver, ISO, and other styles

18

Bishop, Malachy, and Michael Frain. "Development and Initial Analysis of Multiple Sclerosis Self-Management Scale." International Journal of MS Care 9, no. 2 (2007): 35–42. http://dx.doi.org/10.7224/1537-2073-9.2.35.

Full text

Abstract:

This article describes the development and initial psychometric analysis of the Multiple Sclerosis Self-Management Scale (MSSM). The scale was developed to provide a comprehensive and psycho-metrically sound assessment of self-management knowledge and practices among adults with multiple sclerosis (MS). Items were developed based on a review of the MS and self-management literature and professional consultation. The scale was refined after pilot testing, and the reliability, validity, and factor structure of the refined scale were then assessed in a sample of 266 adults with MS. Construct vali

APA, Harvard, Vancouver, ISO, and other styles

19

Gaurai, Gharote* Khyati Bhatt Ujwal Yeole Rasika Pense Paurnima Pawar Sweta Kulkarni. "IMPACT OF RESISTANCE TRAINING ON BALANCE, GAIT AND FATIGUE IN MULTIPLE SCLEROSIS." Indian Journal of Medical Research and Pharmaceutical Sciences 3```, no. 12 (2016): 45–48. https://doi.org/10.5281/zenodo.222151.

Full text

Abstract:

<strong>Introduction:</strong> Multiple sclerosis (MS) is the most prevalent progressive neurodegenerative disease among young adults.Multiple sclerosis (MS) is an autoimmune disease characterized by inflammation, selective demyelination and gliosis. It causes both acute and chronic symptoms and can result in significant disability and impaired quality of life. The vicious cycle of decreased activity contributes to increased disability, and reduced quality of life. However, regular exercise can improve daily activity,cardiovascular fitness,muscle strength,health perception, and fatiguein perso

APA, Harvard, Vancouver, ISO, and other styles

20

Freeman, Jenny, Terry Gorst, Jodielin Ofori, and Jonathan Marsden. "Evaluation of the Multiple Sclerosis Spasticity Scale 88: A Short Report." Rehabilitation Process and Outcome 8 (January 2019): 117957271882351. http://dx.doi.org/10.1177/1179572718823510.

Full text

Abstract:

Background: The Multiple Sclerosis Spasticity Scale 88 (MSSS-88) is designed to capture the patient experience and impact of spasticity, but there is limited evaluation against clinician-rated measures of spasticity. Objective: To evaluate the convergent validity and responsiveness of the MSSS-88. Design: Longitudinal study. Setting: University Laboratory. Subjects: Thirty-four people with multiple sclerosis. Methods: People with multiple sclerosis (MS; n = 34) completed the self-reported 12-item Multiple Sclerosis Walking Scale, Multiple Sclerosis Spasticity Scale, Barthel Index alongside the

APA, Harvard, Vancouver, ISO, and other styles

21

David Ruban, Sabina, Claudia Christina Hilt, and Thor Petersen. "Quality of life in multiple sclerosis: The differential impact of motor and cognitive fatigue." Multiple Sclerosis Journal - Experimental, Translational and Clinical 7, no. 1 (2021): 205521732199604. http://dx.doi.org/10.1177/2055217321996040.

Full text

Abstract:

Background Multiple sclerosis is a chronic disease leading to reduced quality of life. Objectives To investigate whether motor and cognitive fatigue impact differently on aspects of quality of life among patients with multiple sclerosis, independently from bodily disability. Methods 79 patients with multiple sclerosis from Aalborg University Hospital, Denmark were included in an observational, cross-sectional study. Each subject completed two separate questionnaires regarding fatigue (Fatigue Scale for Motor and Cognitive Functions and Modified Fatigue Impact Scale) and one regarding quality o

APA, Harvard, Vancouver, ISO, and other styles

22

Senders, Angela, Dennis Bourdette, Douglas Hanes, Vijayshree Yadav, and Lynne Shinto. "Perceived Stress in Multiple Sclerosis." Journal of Evidence-Based Complementary & Alternative Medicine 19, no. 2 (2014): 104–11. http://dx.doi.org/10.1177/2156587214523291.

Full text

Abstract:

Stressful life events are associated with worsening neurological symptoms and decreased quality of life in multiple sclerosis (MS). Mindful consciousness can alter the impact of stressful events and has potential to improve health outcomes in MS. This study evaluated the relationship between trait mindfulness and perceived stress, coping, and resilience in people with MS. Quality of life was assessed as a secondary outcome. One hundred nineteen people with confirmed MS completed the Five-Facet Mindfulness Questionnaire, Perceived Stress Scale, Brief Coping Orientation for Problem Experiences,

APA, Harvard, Vancouver, ISO, and other styles

23

Ayatollahi, P., S. Nafissi, MR Eshraghian, H. Kaviani, and A. Tarazi. "Impact of depression and disability on quality of life in Iranian patients with multiple sclerosis." Multiple Sclerosis Journal 13, no. 2 (2007): 275–77. http://dx.doi.org/10.1177/1352458506070960.

Full text

Abstract:

Multiple sclerosis (MS) can influence all aspects of a patient's health. This study determines the main factors affecting quality of life (QoL) in Iranian MS patients. QoL (Multiple Sclerosis Impact Scale; MSIS-29), disability (Expanded Disability Status Scale; EDSS) and depression (Beck Depression Inventory; BDI) were assessed in 106 MS patients. EDSS, clinical course and MS duration significantly correlated with physical MSIS-29. Depression highly correlated with both physical and psychological MSIS-29. Regression analyses showed that depression and EDSS predicted physical health. Psychologi

APA, Harvard, Vancouver, ISO, and other styles

24

Riazi, A., A. J. Thompson, and J. C. Hobart. "Self-efficacy predicts self-reported health status in multiple sclerosis." Multiple Sclerosis Journal 10, no. 1 (2004): 61–66. http://dx.doi.org/10.1191/1352458504ms986oa.

Full text

Abstract:

Self-efficacy is a belief that one can competently cope with a challenging situation. If self-efficacy is a strong predicto r of health status in multiple sclerosis (MS), it may be an important area to target in clinical practice, as such beliefs may be modifiable. The aim of this study was to examine the predictive value of self-efficacy on self-reported health status in MS. Eighty-nine people with MS completed the Multiple Sclerosis Self-efficacy Scale (MSSE function and control scales), the Multiple Sclerosis Impact Scale (MSIS-29), and the Multiple Sclerosis Walking Scale (MSWS-12) at two

APA, Harvard, Vancouver, ISO, and other styles

25

Costelloe, L., K. O'Rourke, C. McGuigan, C. Walsh, N. Tubridy, and M. Hutchinson. "The longitudinal relationship between the patient-reported Multiple Sclerosis Impact Scale and the clinician-assessed Multiple Sclerosis Functional Composite." Multiple Sclerosis Journal 14, no. 2 (2007): 255–58. http://dx.doi.org/10.1177/1352458507081274.

Full text

Abstract:

Background To examine the longitudinal relationship between the patient-rated Multiple Sclerosis Impact Scale (MSIS-29) and the doctor-reported Multiple Sclerosis Functional Composite (MSFC). Methods Two-hundred and four MS patients at baseline and 150 patients one to three years later had MSFC and MSIS-29 assessments. Cross-sectional correlations between these measures and correlations of change in scores were examined. Minimally important change (MIC) in the MSFC was defined at either 0.5 or 0.32 SD from baseline. Effect sizes (ES) were calculated. Results Validity: The MSIS-29 physical corr

APA, Harvard, Vancouver, ISO, and other styles

26

Lincoln, Nadina B., Lucy E. Bradshaw, Cris S. Constantinescu, et al. "Cognitive rehabilitation for attention and memory in people with multiple sclerosis: a randomized controlled trial (CRAMMS)." Clinical Rehabilitation 34, no. 2 (2019): 229–41. http://dx.doi.org/10.1177/0269215519890378.

Full text

Abstract:

Objective: To assess the clinical and cost-effectiveness of cognitive rehabilitation for attention and memory problems in people with multiple sclerosis. Design: Multicentre, pragmatic, randomized controlled trial. Setting: Community Participants: People with multiple sclerosis aged 18–69 years, who reported cognitive problems in daily life and had cognitive problems on standardized assessment. Interventions: A group cognitive rehabilitation programme delivered in 10 weekly sessions in comparison with usual care. Main measures: The primary outcome was the Multiple Sclerosis Impact Scale Psycho

APA, Harvard, Vancouver, ISO, and other styles

27

O'Connell, K., M. Duggan, L. Buckley, M. Hutchinson, N. Tubridy, and C. McGuigan. "Longitudinal assessment of the multiple sclerosis impact scale (MSIS-29) amongst A treated relapsing remitting multiple sclerosis cohort." Journal of the Neurological Sciences 333 (October 2013): e374. http://dx.doi.org/10.1016/j.jns.2013.07.1364.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Doward, LC, SP McKenna, DM Meads, J. Twiss, and BJ Eckert. "The development of patient-reported outcome indices for multiple sclerosis (PRIMUS)." Multiple Sclerosis Journal 15, no. 9 (2009): 1092–102. http://dx.doi.org/10.1177/1352458509106513.

Full text

Abstract:

Background Complex diseases such as multiple sclerosis (MS) present dilemmas over the choice of patient-reported outcome measures as no single scale can inform on all types of MS impact from the patient’s perspective. Objective To develop an outcome tool, the Patient-Reported Indices for Multiple Sclerosis (PRIMUS), to assess MS symptoms, activities, and quality of life. Methods PRIMUS content was derived from qualitative interviews with UK MS patients and checked by clinical experts. Semi-structured cognitive debriefing interviews assessed scale face and content validity. PRIMUS scaling prope

APA, Harvard, Vancouver, ISO, and other styles

29

Bamer, AM, KL Johnson, D. Amtmann, and GH Kraft. "Prevalence of sleep problems in individuals with multiple sclerosis." Multiple Sclerosis Journal 14, no. 8 (2008): 1127–30. http://dx.doi.org/10.1177/1352458508092807.

Full text

Abstract:

Background Sleep disturbance in multiple sclerosis has received little research attention despite the potential influence it may have on disease impact. Objective To estimate the prevalence of sleep disorders in a large community sample of individuals with multiple sclerosis. Methods A cross-sectional self-report survey of 1063 persons with multiple sclerosis. Sleep was assessed using the Women's Health Initiative Insomnia Rating Scale and Medical Outcomes Study Sleep measure. Results The prevalence of sleep problems in multiple sclerosis is significantly higher than in the general population

APA, Harvard, Vancouver, ISO, and other styles

30

Jorge, Francielle Fontana, Alessandro Finkelsztejn, and Luciano Palmeiro Rodrigues. "Motor symptoms and the quality of life of relapsing-remitting multiple sclerosis patients in a specialized center in South of Brazil." Arquivos de Neuro-Psiquiatria 79, no. 10 (2021): 895–99. http://dx.doi.org/10.1590/0004-282x-anp-2020-0315.

Full text

Abstract:

Abstract Background: Spasticity, fatigue, muscle weakness and changes in gait are some of the main motor symptoms of Multiple Sclerosis (MS). These changes can interfere with the patients’ quality of life. Objective: To characterize the motor and quality of life symptoms in patients with relapsing-remitting Multiple Sclerosis at a specialized center. Methods: Fifty five patients at the Neuroimmunology Outpatient Clinic of the Hospital de Clínicas de Porto Alegre were evaluated for fatigue (Fatigue Severity Scale — FSS), walking ability (Functional Ambulation Categories — FAC), impact of MS on

APA, Harvard, Vancouver, ISO, and other styles

31

Dymecka, Joanna, and Mariola Bidzan. "Biomedical Variables and Adaptation to Disease and Health-Related Quality of Life in Polish Patients with MS." International Journal of Environmental Research and Public Health 15, no. 12 (2018): 2678. http://dx.doi.org/10.3390/ijerph15122678.

Full text

Abstract:

The aim of this research was to assess the level of adaptation to multiple sclerosis (Sclerosis multiplex; MS) and health-related quality of life (HRQoL) of the study population as well as to determine the relationship between biomedical factors related to the course of multiple sclerosis, adaptation to the disease, and HRQoL. Analysis of medical records, clinical and psychological interviews, the Extended Disability Status Scale (EDSS), Guy’s Neurological Disability Scale (GNDS), the Acceptance of Illness Scale (AIS), and the Multiple Sclerosis Impact Scale 29 (MSIS-29) were collected from 13

APA, Harvard, Vancouver, ISO, and other styles

32

Sonder, Judith M., Lisanne J. Balk, Libertje VAE Bosma, Chris H. Polman, and Bernard MJ Uitdehaag. "Do patient and proxy agree? Long-term changes in multiple sclerosis physical impact and walking ability on patient-reported outcome scales." Multiple Sclerosis Journal 20, no. 12 (2014): 1616–23. http://dx.doi.org/10.1177/1352458514529173.

Full text

Abstract:

Background: Patient-reported outcome scales (PROs) are useful in monitoring changes in multiple sclerosis (MS) over time. Although these scales are reliable and valid measures in longitudinal studies in MS patients, it is unknown what the impact is when obtaining longitudinal data from proxies. Objective: The objective of this paper is to compare longitudinal changes in patient and proxy responses on PROs assessing physical impact of MS and walking ability. Methods: In a prospective observational study, data on the Multiple Sclerosis Impact Scale (MSIS-29 physical) and Multiple Sclerosis Walki

APA, Harvard, Vancouver, ISO, and other styles

33

Nicholas, Richard S., Martin L. Heaven, Rodden M. Middleton, et al. "Personal and societal costs of multiple sclerosis in the UK: A population-based MS Registry study." Multiple Sclerosis Journal - Experimental, Translational and Clinical 6, no. 1 (2020): 205521732090172. http://dx.doi.org/10.1177/2055217320901727.

Full text

Abstract:

Objectives To investigate through survey and data linkage, healthcare resource use and costs (except drugs), including who bears the cost, of multiple sclerosis in the United Kingdom by disease severity and type. Methods The United Kingdom Multiple Sclerosis Register deployed a cost of illness survey, completed by people with multiple sclerosis and linked this with data within the United Kingdom Multiple Sclerosis Register and from their hospital records. Resource consumption was categorised as being medical or non-medical and costed by National Health Service and social services estimates for

APA, Harvard, Vancouver, ISO, and other styles

34

Debouverie, M., S. Pittion-Vouyovitch, S. Louis, and F. Guillemin. "Validity of a French version of the fatigue impact scale in multiple sclerosis." Multiple Sclerosis Journal 13, no. 8 (2007): 1026–32. http://dx.doi.org/10.1177/1352458507077942.

Full text

Abstract:

Purpose Fatigue is a frequent and common symptom of multiple sclerosis (MS) that can interfere with patients' everyday activities. There is no objective scale for assessing fatigue in French MS patients. The objective of this study was to adapt an English language scale for use with French patients. Methods The Fatigue Impact Scale was translated and culturally adapted into French by a committee of medical and linguistic specialists. The psychometric properties of this new instrument, called EMIF-SEP were assessed. Results EMIF-SEP is composed of 40 items. Four dimensions of this scale (cognit

APA, Harvard, Vancouver, ISO, and other styles

35

Huh, So-Young, Jungnam Joo, Su-Hyun Kim, et al. "Validity of Korean Versions of the Multiple Sclerosis Impact Scale and the Multiple Sclerosis International Quality of Life Questionnaire." Journal of Clinical Neurology 10, no. 2 (2014): 148. http://dx.doi.org/10.3988/jcn.2014.10.2.148.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Adlard, NE, R. Rendas-Baum, JB Bjorner, K. Rychlec, V. Khurana, and J. Medin. "PRM197 - RESPONDER DEFINITION OF THE MULTIPLE SCLEROSIS IMPACT SCALE (MSIS)-29 V2 AMONG PATIENTS WITH SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS." Value in Health 21 (October 2018): S390. http://dx.doi.org/10.1016/j.jval.2018.09.2315.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Motaharinezhad, Fatemeh, Shahriar Parvaneh, and Setareh Ghahari. "Multiple Sclerosis Walking Scale-12 (MSWS-12) and its Relationship With Fatigue in People With Multiple Sclerosis." Function and Disability Journal 3, no. 1 (2020): 53–60. http://dx.doi.org/10.32598/fdj.3.10.

Full text

Abstract:

Background and Objectives: Walking disorder is one of the most important manifestations of multiple sclerosis (MS), and indicates the progression of the disease. Fatigue and walking are considered as key symptoms affecting the patient’s quality of life. Therefore, this study aimed to investigate the relationship between walking status and fatigue, in people with MS. Methods: A total number of 60 Iranian patients with MS completed the Persian version of the Multiple Sclerosis Walking Scale-12 (MSWS-12), the Modified Fatigue Impact Scale, and the Hospital Anxiety and Depression Scale. Data were

APA, Harvard, Vancouver, ISO, and other styles

38

Catalan, Mauro, Alessandra De Michiel, Alessio Bratina, et al. "Treatment of Fatigue in Multiple Sclerosis Patients: A Neurocognitive Approach." Rehabilitation Research and Practice 2011 (2011): 1–5. http://dx.doi.org/10.1155/2011/670537.

Full text

Abstract:

The objective of the study was to treat fatigue in patients with multiple sclerosis (MS) by a neurocognitive rehabilitation program aimed at improving motor planning by using motor imagery (MI). Twenty patients with clinically definite MS complaining of fatigue were treated for five weeks with exercises of neurocognitive rehabilitation twice a week. Patients were evaluated by Fatigue Severity Scale (FSS), Modified Fatigue Impact Scale (MFIS), MSQoL54, Expanded Disability Status Scale (EDSS), and MS Functional Composite (MSFC). After treatment, a decrease in fatigue was detected with both FSS (

APA, Harvard, Vancouver, ISO, and other styles

39

Cleanthous, Sophie, Stefan Cano, Elizabeth Kinter, et al. "Measuring the impact of multiple sclerosis: Enhancing the measurement performance of the Multiple Sclerosis Impact Scale (MSIS-29) using Rasch Measurement Theory (RMT)." Multiple Sclerosis Journal – Experimental, Translational and Clinical 3, no. 3 (2017): 205521731772591. http://dx.doi.org/10.1177/2055217317725917.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Phillips, Glenn A., Kathleen W. Wyrwich, Shien Guo, et al. "Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening." Multiple Sclerosis Journal 20, no. 13 (2014): 1753–60. http://dx.doi.org/10.1177/1352458514530489.

Full text

Abstract:

Background: The 29-item Multiple Sclerosis Impact Scale (MSIS-29) was developed to examine the impact of multiple sclerosis (MS) on physical and psychological functioning from a patient’s perspective. Objective: To determine the responder definition (RD) of the MSIS-29 physical impact subscale (PHYS) in a group of patients with relapsing–remitting MS (RRMS) participating in a clinical trial. Methods: Data from the SELECT trial comparing daclizumab high-yield process with placebo in patients with RRMS were used. Physical function was evaluated in SELECT using three patient-reported outcomes mea

APA, Harvard, Vancouver, ISO, and other styles

41

Tamaš, Olivera, Marija Kovačević, Aleksandra Dobrodolac, et al. "Validation of the Fatigue Impact Scale in Multiple Sclerosis Patients in Serbia." Brain Sciences 14, no. 8 (2024): 825. http://dx.doi.org/10.3390/brainsci14080825.

Full text

Abstract:

Fatigue is one of the most frequent complaints of patients with multiple sclerosis (MS). The Fatigue Impact Scale (FIS), one of the 30 available fatigue questionnaires, is commonly applied because it evaluates multidimensional aspects of fatigue. The chief objectives of this study were to validate FIS and evaluate the psychometric properties of MS patients in Serbia. One hundred and twenty-one (121) MS patients and one hundred and twenty-two (122) age-, gender- and education-matched healthy control (HC) subjects completed the FIS and the Beck Depression Inventory. Internal consistency of the F

APA, Harvard, Vancouver, ISO, and other styles

42

Losonczi, Erika, Krisztina Bencsik, Cecília Rajda, Gyula Lencsés, Margit Török, and László Vécsei. "Validation of the Fatigue Impact Scale in Hungarian patients with multiple sclerosis." Quality of Life Research 20, no. 2 (2010): 301–6. http://dx.doi.org/10.1007/s11136-010-9749-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Mills, R. J., C. A. Young, J. F. Pallant, and A. Tennant. "Rasch analysis of the Modified Fatigue Impact Scale (MFIS) in multiple sclerosis." Journal of Neurology, Neurosurgery & Psychiatry 81, no. 9 (2010): 1049–51. http://dx.doi.org/10.1136/jnnp.2008.151340.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Rogić Vidaković, Maja, Nataša Šimić, Ana Poljičanin, Matilda Nikolić Ivanišević, Jerković Ana, and Zoran Đogaš. "Psychometric properties of the Croatian version of the depression, anxiety, and stress scale-21 and multiple sclerosis impact scale-29 in multiple sclerosis patients." Multiple Sclerosis and Related Disorders 50 (May 2021): 102850. http://dx.doi.org/10.1016/j.msard.2021.102850.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Grus, Cyril. "Monitoring the relationship between overactive bladder and mobility disorders in women with multiple sclerosis." Česká gynekologie 88, no. 5 (2023): 353–58. http://dx.doi.org/10.48095/cccg2023353.

Full text

Abstract:

Summary: Background: Currently, there is a lack of studies monitoring the relationship between lower urinary tract symptoms and mobility disorders in women with multiple sclerosis. The aim of this study was to monitor the relationship between overactive bladder and mobility impairments in women with multiple sclerosis. Methods: A number of 106 female patients with multiple sclerosis (MS) with relapsing-remitting (RR) form, disability stage: EDSS ≤ 6.5, from the specialized outpatient clinic of the Department of Neurology, Faculty of Medicine, University of Medical Sciences in Košice. Urinary l

APA, Harvard, Vancouver, ISO, and other styles

46

Côté, I., DA Trojan, M. Kaminska, et al. "Impact of sleep disorder treatment on fatigue in multiple sclerosis." Multiple Sclerosis Journal 19, no. 4 (2012): 480–89. http://dx.doi.org/10.1177/1352458512455958.

Full text

Abstract:

Background: We recently reported that sleep disorders are significantly associated with fatigue in multiple sclerosis (MS). Objective: The objective of this paper is to assess the effects of sleep disorder treatment on fatigue and related clinical outcomes in MS. Methods: This was a controlled, non-randomized clinical treatment study. Sixty-two MS patients completed standardized questionnaires including the Fatigue Severity Scale (FSS), Multidimensional Fatigue Inventory (MFI), Epworth Sleepiness scale (ESS) and Pittsburgh Sleep Quality Index (PSQI), and underwent polysomnography (PSG). Patien

APA, Harvard, Vancouver, ISO, and other styles

47

Hoogervorst, E. LJ, J. NP Zwemmer, B. Jelles, C. H. Polman, and B. MJ Uitdehaag. "Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability." Multiple Sclerosis Journal 10, no. 5 (2004): 569–74. http://dx.doi.org/10.1191/1352458504ms1078oa.

Full text

Abstract:

Objective: To validate the newly developed Multiple Sclerosis Impact Scale (MSIS-29) in a large, well characterized, independent group of MS patients by investigating the relation between the MSIS-29 and the Guy’s Neurological Disability Scale (GNDS), the Expanded Disability Status Scale (EDSS) and the MS Functional Composite (MSFC). Methods: Two hundred MS patients were recruited at our outpatient department. At the same visit GNDS, EDSS, MSFC and MSIS-29 were assessed. Data obtained from GNDS, EDSS and MSFC assessment were compared to both physical and psychological impact scores of the MSIS

APA, Harvard, Vancouver, ISO, and other styles

48

Edmonds, Polly, Sam Hart, Wei Gao, et al. "Palliative care for people severely affected by multiple sclerosis: evaluation of a novel palliative care service." Multiple Sclerosis Journal 16, no. 5 (2010): 627–36. http://dx.doi.org/10.1177/1352458510364632.

Full text

Abstract:

Multiple sclerosis results in both physical and psychological disability but some patients have needs that are not adequately met by existing services. Our objective was to explore whether a new palliative care service improved outcomes for people severely affected by multiple sclerosis. A delayed intervention randomized controlled trial was undertaken with multiple sclerosis patients deemed by staff to have palliative care needs. The intervention was a multiprofessional palliative care team assessment and follow-up. The intervention group was offered the team immediately (fast track, FI); the

APA, Harvard, Vancouver, ISO, and other styles

49

Filipi, Mary L., M. Patricia Leuschen, Jessie Huisinga, et al. "Impact of Resistance Training on Balance and Gait in Multiple Sclerosis." International Journal of MS Care 12, no. 1 (2010): 6–12. http://dx.doi.org/10.7224/1537-2073-12.1.6.

Full text

Abstract:

Multiple sclerosis (MS) is an incurable neurodegenerative disease whose symptoms are only partially relieved by pharmaceutical intervention. Disability due to this disease process can impede activities of daily living and decrease quality of life, both for MS patients and for their care partners and families. A nonrandomized, nonblinded prospective cohort study of 45 patients with MS was undertaken to investigate the impact of an exercise program emphasizing resistance training on balance and gait. This article presents data for the first 33 participants to complete the study protocol. The exe

APA, Harvard, Vancouver, ISO, and other styles

50

Farran, Natali, Batoul R. Safieddine, Mariam Bayram, et al. "Factors affecting MS patients’ health-related quality of life and measurement challenges in Lebanon and the MENA region." Multiple Sclerosis Journal - Experimental, Translational and Clinical 6, no. 1 (2020): 205521731984846. http://dx.doi.org/10.1177/2055217319848467.

Full text

Abstract:

Background In the Middle East and North Africa (MENA) region, few studies explored the quality of life of multiple sclerosis patients and the factors affecting it. Objective The objective of this study was to explore studies on multiple sclerosis quality of life in the MENA area through a comprehensive literature review. To validate the Multiple sclerosis international Quality of Life (MusiQoL) and Modified Fatigue Impact Scale (MFIS) in Arabic, and investigate the impact of sociodemographic and clinical variables of Lebanese multiple sclerosis patients on quality of life. Methods As part of a

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!